There’s two ways of looking at this …
They wanted to give an opportunity for long term shareholders to participate at a low cost as this will be the last chance before the interim results are known.
If successful …
At that point it will no longer be shareholders funding any further .
It’s good to know …. In March 2024, the Company updated the market to report that 11 patients had
been dosed in the Phase 2a trial at that time
.
There’s two ways of looking at this … They wanted to give an...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
-0.005(3.85%) |
Mkt cap ! $34.27M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 12.0¢ | $120.7K | 983.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 279677 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 16317 | 1 |
View Market Depth
| Last trade - 15.44pm 23/08/2024 (20 minute delay) ? |
| ATX (ASX) Chart |